This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_URINARY_NOS_EXALLC for full statistics.
Carcinoma in situ, other and unspecified urinary organs
CD2_INSITU_URINARY_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
19 |
4. Check minimum number of eventsNone |
19 |
5. Include endpointsNone |
19 |
6. Filter based on genotype QC (FinnGen only) |
19 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D09
- Name in latin
- Carcinoma in situ organorum urinariorum aliorum sive non specificatorum
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, other and unspecified urinary organs
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ, other and unspecified urinary organs
- Carcinoma in situ of other and unspecified sites
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 19 | 9 | 10 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | 56.60 | 42.26 | 69.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
7
5
20.80
5.01
12.1
4.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
51
3.72
2.11
3.8
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
10
42
3.88
2.03
2.2
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
56
3.27
1.74
6.8
3.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
14
4.44
1.73
9.2
3.1
e6/l
0.0
0.1
—
5
14
(3041096) Erythrocytes [Presence] in Urine by Automated
9
40
3.35
1.71
2.4
4.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
11
59
3.03
1.64
8.3
4.7
—
—
—
0
0
(3013512) EKG study
10
55
2.71
1.39
3.2
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
10
55
2.71
1.39
3.6
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
8
40
2.71
1.33
4.9
5.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
7
115
0.38
1.27
37.4
22.5
g/l
323.1
330.8
—
7
115
(3015736) pH of Urine
10
58
2.52
1.15
3.8
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
11
69
2.40
1.08
14.1
12.9
e9/l
0.0
0.0
0.00
11
58
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
53
2.32
0.95
4.7
5.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
11
75
2.10
0.84
10.2
6.3
e9/l
0.0
0.0
0.11
11
66
(3001604) Monocytes [#/volume] in Blood
11
75
2.10
0.84
10.2
6.1
e9/l
0.6
0.6
0.26
11
65
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
34
2.11
0.67
4.7
3.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
11
78
1.97
0.65
10.3
6.5
e9/l
0.2
0.2
0.48
11
71
(3019198) Lymphocytes [#/volume] in Blood
11
78
1.97
0.65
10.3
6.3
e9/l
1.6
1.7
0.21
11
71
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
19
0.00
0.64
0.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
10
75
1.70
0.48
3.2
10.0
inr
1.1
1.4
—
5
25
(3037467) Urinalysis macro (dipstick) panel - Urine
13
103
1.83
0.48
7.2
4.8
—
—
—
0
0
(3044889) 12 lead EKG panel
13
105
1.75
0.47
4.6
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
6
42
1.62
0.41
5.8
7.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
8
64
1.43
0.34
1.6
2.9
ng/l
829.7
977.2
—
8
56
(3013650) Neutrophils [#/volume] in Blood by Automated count
11
93
1.43
0.32
17.0
10.8
e9/l
3.4
4.0
0.87
11
79
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
10
0.00
0.22
0.0
2.7
—
4.9
—
0
10
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
10
0.00
0.22
0.0
2.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
12
0.00
0.22
0.0
6.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
12
0.00
0.22
0.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5
46
1.12
0.10
2.6
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6
51
1.26
0.10
3.3
2.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
8
73
1.16
0.09
3.4
2.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
3.4
—
0.9
—
0
7
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
2.1
—
0
7
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
7
0.00
0.00
0.0
4.3
—
46.4
—
0
7
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
2.2
—
5.6
—
0
5
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.1
—
24.6
—
0
9
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3036489) Thrombin time
0
5
0.00
0.00
0.0
3.0
—
22.2
—
0
5
(3020961) Endomysium IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
15.8
—
0
5
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7
73
0.94
0.00
5.0
4.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
3.0
—
0.8
—
0
6
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
3.0
—
1.4
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
24.2
—
0
5
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8
82
0.96
0.00
10.1
7.0
mmol/l
1.2
1.2
—
8
76
(3028626) Oxygen [Partial pressure] in Capillary blood
0
6
0.00
0.00
0.0
3.0
—
8.4
—
0
6
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
2.5
—
80.3
—
0
6
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
3.8
—
26.3
—
0
9
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
2.2
—
3.2
—
0
5
(3008898) HLA-B27 [Presence]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_URINARY_NOS – Carcinoma in situ, other and unspecified urinary organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).